Predisurge Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $6.85M

  • Investors
  • 7

Predisurge General Information

Description

Developer of decision-making tools designed to offer secure cardiovascular interventions. The company's platform offers the design and implant cardiovascular medical devices and the creation of patient-specific digital twins, numerical models simulating arteries and valves, enabling physicians to care for patients more personally and securely by providing the right data at each procedural stage, from preoperative planning to follow-up, based on our numerical simulation technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Station, 2 Parvis Pierre Laroque
  • 42000 Saint-Étienne
  • France
Primary Industry
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • One Station, 2 Parvis Pierre Laroque
  • 42000 Saint-Étienne
  • France

Predisurge Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Predisurge Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Jul-2026 $6.85M Completed Generating Revenue
6. Later Stage VC 29-May-2026 Completed Generating Revenue
5. Later Stage VC (Series A) 11-Sep-2023 Completed Generating Revenue
4. Grant 23-Mar-2022 Completed Startup
3. Seed Round 01-Jan-2020 Completed Startup
2. Accelerator/Incubator 01-Jan-2019 Completed Startup
1. Grant 01-Jan-2018 $237K Completed Startup
To view Predisurge’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Predisurge Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of decision-making tools designed to offer secure cardiovascular interventions. The company's platform offers
Decision/Risk Analysis
Saint-Étienne, France
40 As of 2026

Milan, Italy

Hangzhou, China
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Predisurge Competitors (3)

One of Predisurge’s 3 competitors is allstent, a Accelerator/Incubator Backed company based in Milan, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
allstent Accelerator/Incubator Backed Milan, Italy
Artery Flow Venture Capital-Backed Hangzhou, China
ViTAA Venture Capital-Backed Montreal, Canada
You’re viewing 3 of 3 competitors. Get the full list »

Predisurge Patents

Predisurge Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023336563-A1 Method for modelling an endoprothesis implanted in a portion of a patient aorta Pending 08-Sep-2022
EP-4335402-A1 Method for modelling an endoprothesis implanted in a portion of a patient aorta Active 08-Sep-2022
EP-4335402-B1 Method for modelling an endoprothesis implanted in a portion of a patient aorta Active 08-Sep-2022
EP-4583801-A1 Method for modelling an endoprothesis implanted in a portion of a patient aorta Pending 08-Sep-2022
US-20260060751-A1 Method for modelling an endoprothesis implanted in a portion of a patient aorta Pending 08-Sep-2022 A61B34/10
To view Predisurge’s complete patent history, request access »

Predisurge Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Predisurge Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
M.I.Tech Corporation Minority
Credit Agricole Lhl Capital Innovation Venture Capital Minority
Saint Victor Capital Venture Capital Minority
UI Investissement PE/Buyout Minority
European Innovation Council Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Predisurge FAQs

  • When was Predisurge founded?

    Predisurge was founded in 2017.

  • Where is Predisurge headquartered?

    Predisurge is headquartered in Saint-Étienne, France.

  • What is the size of Predisurge?

    Predisurge has 40 total employees.

  • What industry is Predisurge in?

    Predisurge’s primary industry is Decision/Risk Analysis.

  • Is Predisurge a private or public company?

    Predisurge is a Private company.

  • What is Predisurge’s current revenue?

    The current revenue for Predisurge is .

  • How much funding has Predisurge raised over time?

    Predisurge has raised $16.8M.

  • Who are Predisurge’s investors?

    M.I.Tech, Credit Agricole Lhl Capital Innovation, Saint Victor Capital, UI Investissement, and European Innovation Council are 5 of 7 investors who have invested in Predisurge.

  • Who are Predisurge’s competitors?

    allstent, Artery Flow, and ViTAA are competitors of Predisurge.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process